ATE509617T1 - Phenytoinformulierungen und ihre verwendungen in der wundheilung - Google Patents

Phenytoinformulierungen und ihre verwendungen in der wundheilung

Info

Publication number
ATE509617T1
ATE509617T1 AT05776796T AT05776796T ATE509617T1 AT E509617 T1 ATE509617 T1 AT E509617T1 AT 05776796 T AT05776796 T AT 05776796T AT 05776796 T AT05776796 T AT 05776796T AT E509617 T1 ATE509617 T1 AT E509617T1
Authority
AT
Austria
Prior art keywords
phenyloin
matrix
wound healing
gel
entrapped
Prior art date
Application number
AT05776796T
Other languages
English (en)
Inventor
John Kelly
Cormac Kennedy
Clare Meaney
Original Assignee
Royal College Surgeons Ireland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Royal College Surgeons Ireland filed Critical Royal College Surgeons Ireland
Application granted granted Critical
Publication of ATE509617T1 publication Critical patent/ATE509617T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0076—Sprayable compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Materials For Medical Uses (AREA)
AT05776796T 2004-08-03 2005-08-02 Phenytoinformulierungen und ihre verwendungen in der wundheilung ATE509617T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59847904P 2004-08-03 2004-08-03
PCT/EP2005/008344 WO2006013084A1 (en) 2004-08-03 2005-08-02 Phenytoin formulations, and uses thereof in wound healing

Publications (1)

Publication Number Publication Date
ATE509617T1 true ATE509617T1 (de) 2011-06-15

Family

ID=37846283

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05776796T ATE509617T1 (de) 2004-08-03 2005-08-02 Phenytoinformulierungen und ihre verwendungen in der wundheilung

Country Status (9)

Country Link
US (1) US20090022779A1 (de)
EP (1) EP1786397B1 (de)
JP (1) JP2008508339A (de)
AT (1) ATE509617T1 (de)
AU (1) AU2005268929A1 (de)
CA (1) CA2574555A1 (de)
NO (1) NO20071156L (de)
NZ (1) NZ553024A (de)
WO (1) WO2006013084A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8729121B2 (en) * 2007-06-25 2014-05-20 Adhezion Biomedical, Llc Curing accelerator and method of making
GB0722820D0 (en) 2007-11-21 2008-01-02 Smith & Nephew Vacuum assisted wound dressing
WO2009067711A2 (en) 2007-11-21 2009-05-28 T.J. Smith & Nephew, Limited Suction device and dressing
MX2010005552A (es) 2007-11-21 2010-06-02 Smith & Nephew Aposito para heridas.
GB0723875D0 (en) 2007-12-06 2008-01-16 Smith & Nephew Wound management
US11253399B2 (en) 2007-12-06 2022-02-22 Smith & Nephew Plc Wound filling apparatuses and methods
GB2456389B (en) * 2008-01-15 2010-03-31 Barry Sonenfeld Pharmaceutical and skin compositions comprising emulsifying ointment and water
GB0803564D0 (en) 2008-02-27 2008-04-02 Smith & Nephew Fluid collection
US20110117047A1 (en) * 2008-06-23 2011-05-19 Adhezion Biomedical, Llc Cyanoacrylate tissue adhesives with desirable permeability and tensile strength
CA2753641C (en) * 2009-02-25 2014-09-16 Supratek Pharma, Inc. Bendamustine cyclopolysaccharide compositions
US9061095B2 (en) 2010-04-27 2015-06-23 Smith & Nephew Plc Wound dressing and method of use
GB201011173D0 (en) 2010-07-02 2010-08-18 Smith & Nephew Provision of wound filler
US8287901B2 (en) * 2010-08-11 2012-10-16 Adhezion Biomedical, Llc Wound healing compositions based on cyanoacrylates and 5,5-disubstitutedhydantoins, including phenytoin
GB201020005D0 (en) 2010-11-25 2011-01-12 Smith & Nephew Composition 1-1
WO2012069794A1 (en) 2010-11-25 2012-05-31 Smith & Nephew Plc Composition i-ii and products and uses thereof
US20150159066A1 (en) 2011-11-25 2015-06-11 Smith & Nephew Plc Composition, apparatus, kit and method and uses thereof
US20160120706A1 (en) 2013-03-15 2016-05-05 Smith & Nephew Plc Wound dressing sealant and use thereof
CN103301502A (zh) * 2013-06-18 2013-09-18 王珍 一种妇科医用凝胶敷料及其制备方法
IL267114B1 (en) * 2016-12-06 2024-04-01 Topical Innovations B V Topical phenytoin for the treatment of peripheral neuropathic pain
EP3551182A1 (de) 2016-12-06 2019-10-16 Topical Innovations B.V. Topische pharmazeutische zusammensetzung mit phenytoin und einem (co -)analgetikum zur behandlung von chronischen schmerzen
WO2019072877A1 (en) * 2017-10-10 2019-04-18 Capsugel Belgium Nv GETTING MULTIPARTICULAR COMPOSITIONS
CN108143985A (zh) * 2018-02-28 2018-06-12 苏州凌科特新材料有限公司 一种医用愈肤生物成膜喷剂及其制备方法
CN109331219A (zh) * 2018-11-30 2019-02-15 广州润虹医药科技股份有限公司 一种壳聚糖液体敷料
IL291111B2 (en) * 2019-09-06 2024-01-01 Consejo Nacional De Investigaciones Cientificas Y Tecn Medicinal preparation for the treatment of local wounds
CN111297834B (zh) * 2020-04-19 2023-05-26 田文超 一种退热贴

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036095A (en) * 1989-11-14 1991-07-30 Guy Andermann Therapeutic use of DMDM Hydantoin
US6730323B1 (en) * 1996-12-18 2004-05-04 Care Teck Laboratories, Inc. Microclysmic gel for treatment of tissue trauma and burns
GB2327344A (en) * 1997-07-18 1999-01-27 Ninh Thuy On Pharmaceutical compositions containing phenytoin and either an azole anti-fungal/anti-bacterial agent and/or a silver salt for topical application
US6699849B1 (en) * 1998-02-23 2004-03-02 Cyclops, Ehf. Cyclodextrin complexes of benzodiazepines
US6274168B1 (en) * 1999-02-23 2001-08-14 Mylan Pharmaceuticals Inc. Phenytoin sodium pharmaceutical compositions
CN1466419A (zh) * 2000-09-29 2004-01-07 ���Ͽع����޹�˾ 具有抗菌活性的稳定组合物

Also Published As

Publication number Publication date
EP1786397A1 (de) 2007-05-23
WO2006013084A1 (en) 2006-02-09
NO20071156L (no) 2007-05-03
JP2008508339A (ja) 2008-03-21
US20090022779A1 (en) 2009-01-22
NZ553024A (en) 2009-11-27
EP1786397B1 (de) 2011-05-18
CA2574555A1 (en) 2006-02-09
AU2005268929A1 (en) 2006-02-09

Similar Documents

Publication Publication Date Title
ATE509617T1 (de) Phenytoinformulierungen und ihre verwendungen in der wundheilung
CY1109519T1 (el) Κεκορεσμενες και ακορεστες 3-πυριδυλο-βενζοκυκλοαλκυλομεθυλαμινες για τη θεραπεια πονων, καταθλιψεων και καταστασεων φοβου
DK1797053T3 (da) Phenothiazinium-forbindelse til sårheling
EA200970841A1 (ru) Фармацевтическое применение замещенных амидов
TW200637529A (en) Topical patch cooling preparation and methods for using the same
HK1140377A1 (en) Pharmaceutical use of substituted amides
DE602004011374D1 (de) Transdermale pharmazeutische zusammensetzung
EA200801243A1 (ru) Фармацевтическое применение замещенных амидов
EA200601777A1 (ru) Новое применение пептидных соединений для лечения боли при болезненной диабетической нейропатии
ATE497489T1 (de) Nichtsymmetrisches geliermittel
ATE437896T1 (de) Flüssige dispersionspolymerzusammensetzungen, ihre herstellung und ihre verwendung
ATE448777T1 (de) Mittel für die transdermale verabreichung von nikotin
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
BRPI0500704A (pt) composições de tratamento pessoal reidratáveis
BR0316947A (pt) Liberação iontoforética de rotigotina para o tratamento da doença de parkinson
WO2005016286A3 (en) Pyrazine modulators of cannabinoid receptors
SE0401971D0 (sv) Piperidne derivatives
EA201100020A1 (ru) Композиция для местного применения для лечения актинического кератоза
DE502006007664D1 (de) Verwendung filmbildender haarpflegepolymere aus der gruppe der polyurethane und diese polymere enthaltende pharmazeutische zubereitungen und pflaster
DE502004002571D1 (de) Substituierte 3-pyrrolidin-indol-derivate
WO2006100489A3 (en) A transdermal topical composition and its uses
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение
SE0401970D0 (sv) Novel compounds
CY1109507T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει ενα ελαστομερες οργανοπολυσιλοξανιο και μια διαλυτοποιημενη δραστικη ουσια
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties